BOPA Drug Monographs for Second-line Agents

A guide for members on the prescribing and monitoring of second-line agents, when used in the management of irAEs because of treatment immune-checkpoint inhibitors. Published by the British Oncology Pharmacy Association (BOPA) in collaboration with the IOCN.